Clinical Trial Update: Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction [Phase 1]

View source ↗

Summary

A Phase 1 study of IM96 CAR-T Cell Therapy for advanced gastric adenocarcinoma and esophagogastric junction adenocarcinoma. The trial status is NOT_YET_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Gastric Adenocarcinoma

Drugs mentioned

• IM96 CAR-T cell therapy

Snippet

Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. | Conditions: Adenocarcinoma of Gastric, Adenocarcinoma of Esophagogastric Junction | Phase 1 | Status: NOT_YET_RECRUITING